Akebia Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-9.3621.106.182.98
Price/Sales ratio
3.352.251.631.20
Earnings per Share (EPS)
$-0.32$0.14$0.49$1.02

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-4.84-5.63-2.89-8.41-3.76-2.67-1.10-1.53-0.99-4.47-1.28-3.76
Price/Sales ratio
N/AN/A255.783.633.112.231.311.750.361.190.402.23
Price/Book Value ratio
1.722.615.765.421.011.891.564.9011.28-7.6012.761.01
Price/Cash Flow ratio
-6.52-6.526.78-11.51-6.63-2.90-3.51-1.48-1.44-9.94-1.62-6.63
Price/Free Cash Flow ratio
-6.47-6.477.10-11.19-6.52-2.83-3.50-1.48-1.43-9.94-1.62-6.52
Price/Earnings Growth ratio
-0.011.22-0.050.160.22-0.04-0.150.030.010.08-0.01-0.04
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/A-7442.99%99.65%96.30%56.61%-0.20%28.17%71.02%61.90%68.90%68.90%
Operating Profit Margin
N/AN/A-8889.90%-44.90%-85.75%-85.45%-127.47%-124.22%-21.59%-23.76%-24.12%-85.75%
Pretax Profit Margin
N/AN/A-8843.45%-43.21%-82.74%-85.45%-129.85%-132.42%-31.63%-26.67%-31.63%-82.74%
Net Profit Margin
N/AN/A-8843.45%-43.21%-82.74%-83.48%-118.47%-114.65%-36.22%-26.67%-31.63%-82.74%
Effective Tax Rate
0.55%0.84%0.66%3.63%16.48%2.31%8.75%13.42%-14.52%N/AN/A2.31%
Return on Assets
-33.36%-42.47%-45.21%-21.11%-17.25%-36.26%-54.31%-46.59%-30.13%-21.48%-26.30%-26.30%
Return On Equity
-35.58%-46.34%-199.27%-64.45%-27.03%-70.84%-141.29%-320.27%-1134.75%169.77%-331.73%-70.84%
Return on Capital Employed
-36.44%-46.93%-73.38%-36.34%-24.37%-50.84%-82.37%-98.61%-27.82%-32.61%-31.08%-31.08%
Liquidity Ratios
Current Ratio
16.0411.882.592.481.761.481.98N/AN/AN/A0.721.48
Quick Ratio
16.0411.882.592.481.330.921.650.911.301.021.031.03
Cash ratio
4.764.191.630.480.390.701.220.580.720.420.720.39
Days of Sales Outstanding
N/AN/A8.04K70.1629.2842.3433.1988.1551.2273.6848.8729.28
Days of Inventory outstanding
N/AN/AN/A0.005.42K292.2075.2690.8893.6777.2387.30292.20
Operating Cycle
N/AN/A8.04K70.165.45K334.54108.45179.03144.89150.9299.35334.54
Days of Payables Outstanding
31.708.79K6.424.13K2.03K98.4950.9579.9277.5772.0472.2998.49
Cash Conversion Cycle
N/AN/A8.03K-4.06K3.42K236.0557.5099.1167.3278.88-1.89236.05
Debt Ratios
Debt Ratio
N/AN/AN/AN/A0.010.090.140.180.350.370.970.01
Debt Equity Ratio
N/AN/AN/AN/A0.020.190.381.2713.22-2.9636.660.02
Long-term Debt to Capitalization
N/AN/AN/AN/AN/A0.160.28N/A0.901.750.870.16
Total Debt to Capitalization
N/AN/AN/AN/A0.020.160.280.560.921.500.910.02
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-4.50N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/A-6.49-3.39-1.14-2.59-0.59-0.25-0.76-6.49
Company Equity Multiplier
1.061.094.403.051.561.952.606.8737.66-7.9037.661.56
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/A37.72-0.31-0.46-0.76-0.37-1.18-0.25-0.12-0.25-0.46
Free Cash Flow / Operating Cash Flow Ratio
1.001.000.951.021.011.021.001.001.0011.001.02
Cash Flow Coverage Ratio
N/AN/AN/AN/A-6.49-3.39-1.14-2.59-0.59-0.25-0.76-6.49
Short Term Coverage Ratio
N/AN/AN/AN/A-6.49N/AN/A-2.59-2.28-1.19-2.28-6.49
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A